• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Amicus Therapeutics, Inc. (FOLD)

    -NasdaqGM
    10.96 Up 0.29(2.72%) Mar 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:10.67
    Open:10.73
    Bid:10.73 x 300
    Ask:11.90 x 100
    1y Target Est:16.00
    Beta:2.33
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:10.72 - 11.20
    52wk Range:1.77 - 13.20
    Volume:1,547,117
    Avg Vol (3m):1,909,940
    Market Cap:1.05B
    P/E (ttm):N/A
    EPS (ttm):-0.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    FOLDUp 2.72%1.05B
    SHPGUp 1.04%47.14B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):833.59
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.87
    Quarterly EPS Est (Mar-15) :-0.21
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback